PLIVA 459 Pill - white capsule-shape, 14mm
Pill with imprint PLIVA 459 is White, Capsule-shape and has been identified as Theophylline Extended-Release 300 mg. It is supplied by Pliva Inc.
Theophylline is used in the treatment of Apnea of Prematurity; Asthma, Maintenance; Asthma, acute and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PLIVA 459
Theophylline Extended-Release
- Imprint
- PLIVA 459
- Strength
- 300 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Methylxanthines
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pliva Inc.
- National Drug Code (NDC)
- 50111-0459 (Discontinued)
- Inactive Ingredients
-
hypromellose 2208 (100 mPa.s),
lactose anhydrous,
magnesium stearate,
povidone k30
Note: Inactive ingredients may vary.
More about theophylline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (17)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: methylxanthines
- Breastfeeding
- En español
Patient resources
- Theophylline drug information
- Theophylline (Intravenous) (Advanced Reading)
- Theophylline (Oral) (Advanced Reading)
- Theophylline Extended-Release Tablets
- Theophylline Extended-Release Capsules
Other brands
Theo-Dur, Elixophyllin, Quibron-T/SR, Uniphyl, ... +6 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.